跳至主要内容
临床试验/JPRN-jRCTs031180255
JPRN-jRCTs031180255招募中3 期

JCOG1507: A phase III trial to confirm S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection - BIRDIE

YOSHIDA Kazuhiro0 个研究点目标入组 170 人开始时间: 2019年3月13日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 80age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Histologically proven gastric adenocarcinoma
  • 2) Pathological stage II/III defined by 14th edition of Japanese Classification of Gastric Carcinoma
  • 3) Received R0 gastrectomy with D1+ or D2 lymphadenectomy
  • 4) Either of the following surgery performed;
  • i) Open laparotomy regardless of clinical stage and type of gastrectomy
  • ii) Laparoscopic or laparoscope-assisted gastrectomy regardless of clinical stage and type of gastrectomy
  • 5) Either of the followings:
  • i) Weight loss < 15% and 30 mL/min <= Ccr for the patients received total gastrectomy
  • ii) Weight loss < 15% and 30 mL/min <= Ccr < 80 mL/min for the patients not received total gastrectomy
  • 6) Within 5 to 12 weeks after surgery
  • 7) Aged 80 years old or older
  • 8) Performance status of 0 or 1
  • 9) No gastric stump cancer
  • 10) No previous treatment of chemotherapy, radiation therapy, or molecular-target therapy for any neoplasms. (History of hormone therapy more than one year ago is eligible.)
  • 11) Enough oral intake
  • 12) No dementia, or dementia with family support to continue protocol treatment or examinations
  • 13) Sufficient organ functions
  • 14) No ischemic change on ECG
  • 15) Written informed consent

排除标准

  • 1) Synchronous double/multiple cancer or metachronous double/multiple cancer with progression free period of 5 years or shorter
  • 2) Infectious disease requiring systemic treatment
  • 3) Body temperature of 38 degrees Celsius or higher
  • 4) Severe mental disease
  • 5) Requiring systemic steroid medication (>= 5 mg/day of prednisolone)
  • 6) Under treatment by flucytosine, phenytoin, or warfarin potassium
  • 7) Uncontrolled diabetes mellitus
  • 8) Uncontrolled hypertension
  • 9) Unstable angina pectoris (angina developed or attack worsened within recent 3 weeks) or previous myocardial infarction within 6 months
  • 10) Positive for HBs antigen
  • 11) Severe interstitial pneumonia, severe lung fibrosis, or severe emphysema
  • 12) Surgical morbidity such as infection, leakage, intestinal bleeding, pancreatic fistula, and so on is not improved

研究者

发起方
YOSHIDA Kazuhiro

相似试验